Pfizer Inc. (PFE)
Pfizer (PFE) Beats on Q2 Earnings & Sales, Raises 2024 View
Pfizer (PFE) beats second-quarter estimates for earnings and sales. It raises 2024 earnings as well as revenue expectations.
Here's What Key Metrics Tell Us About Pfizer (PFE) Q2 Earnings
The headline numbers for Pfizer (PFE) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Pfizer (PFE) Tops Q2 Earnings and Revenue Estimates
Pfizer (PFE) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.67 per share a year ago.
Pfizer Stock Rises After Guidance Hike, Earnings Beat.
Drugmaker Pfizer reported quarterly earnings above expectations on Tuesday as it raised full year guidance on the back of strong sales of non-Covid products.
Pfizer upgrades guidance; on track to deliver $4bn of net cost savings
Pfizer Inc's (NYSE:PFE, ETR:PFE) stock is up ahead of the bell after the company raised its annual profit forecast following stronger-than-expected sales of its Covid vaccine and antiviral treatment. The drugmaker now anticipates an annual profit of $2.45 to $2.65 per share, up from its previous forecast of $2.15 to $2.35 per share.
Pfizer Beats Q2 Estimates, Boosts 2024 Outlook
Pfizer's Q2 revenue reaches $13.28 billion, marking a 2% increase year-over-year and surpassing projected $12.96 billion
Pfizer Stock Rises On Earnings Beat, Raised Outlook
Pfizer beat second-quarter views and guided up for the full year. Pfizer stock, already in a buy zone, rose Tuesday.
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
Pfizer reported second-quarter revenue and adjusted earnings that blew past expectations and raised its full-year outlook as the drugmaker works to slash costs. The results come as Pfizer scrambles to stabilize its business and win back Wall Street's favor following the rapid decline in demand for its Covid products.
Pfizer raises annual profit forecast after better-than-expected COVID sales
U.S. drugmaker Pfizer on Tuesday raised its annual profit forecast after reporting better-than-expected sales of its COVID vaccine and antiviral treatment.
Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Pfizer Inc. PFE is scheduled to release its financial results for the second quarter, before the opening bell on Tuesday.
How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings
Pfizer Inc. PFE will release its financial results for the second quarter, before the opening bell on Tuesday.
Prediction: This Will Be Pfizer's Next Big Move
Pfizer is in the midst of a strategic transition to new sources of revenue. It has enough capital to ease that transition by making acquisitions.
